Latest filing published 06 Oct 2021 for Strongbridge Biopharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Stephen J. Long is a declared insider of Strongbridge Biopharma plc, with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 1 October 2021 to 5 October 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 6 October 2021 came the latest disclosure, a transaction in Strongbridge Biopharma plc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations